Chronic kidney disease anemia management: what should be done?


Conference Paper

A transition in the approach to anemia management in nephrology occurred when randomized trials demonstrated that higher hemoglobin targets do not result in better outcomes and may arguably cause harm. Contradicting the speculative conclusions drawn based on earlier observational data, this has resulted in hypotheses regarding the cause of these seemingly disparate but substantively similar messages. The renal community now must struggle with how to incentivize quality care and maximize patient quality of life while minimizing the real safety signal of which we are now aware.

Full Text

Cited Authors

  • Szczech, LA

Published Date

  • 2011

Published In

Volume / Issue

  • 31 / 1-3

Start / End Page

  • 186 - 188

PubMed ID

  • 21228588

Pubmed Central ID

  • 21228588

Electronic International Standard Serial Number (EISSN)

  • 1421-9735

Digital Object Identifier (DOI)

  • 10.1159/000321852

Conference Location

  • Switzerland